Crispr Therapeutics Ag (CRSP)

CapEx to Revenue

31.48%

TTM · Retrieved:

CRSP logo

CRSP CapEx to Revenue

Current (TTM)31.48%
CRSP TTM CapEx/Revenue (31.48% → 31.48%)
More history is needed to export this chart.

CRSP capex to revenue history

Published TTM snapshot. The date records when this current TTM value was retrieved.

Crispr Therapeutics Ag CapEx to Revenue — Published TTM snapshot
RetrievedCapEx to Revenue
31.4815%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.